Form 8-K - Current report:
SEC Accession No. 0001628280-21-014235
Filing Date
2021-07-22
Accepted
2021-07-22 08:15:21
Documents
14
Period of Report
2021-07-22
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K csbr-20210722.htm   iXBRL 8-K 40808
2 EX-99.1 csbr8-k4302021exhibit991.htm EX-99.1 174262
6 GRAPHIC fy2016pr_image1a20a.jpg GRAPHIC 24002
  Complete submission text file 0001628280-21-014235.txt   384773

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT csbr-20210722.xsd EX-101.SCH 1930
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT csbr-20210722_lab.xml EX-101.LAB 21063
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT csbr-20210722_pre.xml EX-101.PRE 10994
7 EXTRACTED XBRL INSTANCE DOCUMENT csbr-20210722_htm.xml XML 9897
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Filer) CIK: 0000771856 (see all company filings)

EIN.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-11504 | Film No.: 211106074
SIC: 2836 Biological Products, (No Diagnostic Substances)